NovaBridge Biosciences (NBP) CIO discloses 874,000 Ordinary Shares stake

Rhea-AI Filing Summary

NovaBridge Biosciences Chief Investment Officer reports initial ownership position. Zhang Xiaofan Neo reports beneficial ownership of 874,000 Ordinary Shares of NovaBridge Biosciences. According to the footnotes, these reported securities are represented by 380,000 American Depositary Shares, where each 10 ADSs represent 23 Ordinary Shares.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Zhang Xiaofan Neo

Role Chief Investment Officer

Type	Security	Shares	Price	Value
holding	Ordinary Shares	--	--	--

Holdings After Transaction: Ordinary Shares — 874,000 shares (Direct)

Footnotes (1)

1. The Ordinary Shares may be represented by American Depositary Shares ("ADS"). Each 10 ADSs represent 23 Ordinary Shares of the Issuer. Reported securities are represented by 380,000 ADSs.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Understanding Insider Trading Forms →

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Zhang Xiaofan Neo

(Last) (First) (Middle)

C/O NOVABRIDGE BIOSCIENCES,

2440 RESEARCH BOULEVARD, SUITE 400

(Street)

ROCKVILLE MARYLAND 20850

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
NovaBridge Biosciences [ NBP ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Investment Officer

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares(1)	874,000(2)	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The Ordinary Shares may be represented by American Depositary Shares ("ADS"). Each 10 ADSs represent 23 Ordinary Shares of the Issuer.

2. Reported securities are represented by 380,000 ADSs.

Remarks:

Exhibit List: Ex. 24.1 - Power of Attorney

	/s/ Xi-Yong (Sean) Fu as attorney-in-fact	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does the NovaBridge Biosciences (NBP) Form 3 filing show for Zhang Xiaofan Neo?

The Form 3 shows that Chief Investment Officer Zhang Xiaofan Neo beneficially owns 874,000 Ordinary Shares of NovaBridge Biosciences, represented by 380,000 ADSs. This is an initial ownership report, not a record of recent share purchases or sales.

How are NovaBridge Biosciences (NBP) Ordinary Shares represented by ADSs in this filing?

The filing states that NovaBridge Ordinary Shares may be represented by American Depositary Shares (ADSs). Each 10 ADSs represent 23 Ordinary Shares. The reported holdings correspond to 380,000 ADSs, which together represent the 874,000 Ordinary Shares disclosed.

Did Zhang Xiaofan Neo buy or sell NovaBridge Biosciences (NBP) shares in this Form 3?

The Form 3 does not report any buy or sell transactions. It is an initial statement of beneficial ownership showing a holding of 874,000 Ordinary Shares, represented by 380,000 ADSs, rather than documenting new trading activity in NovaBridge Biosciences shares.

What insider role does Zhang Xiaofan Neo hold at NovaBridge Biosciences (NBP)?

Zhang Xiaofan Neo is identified as the Chief Investment Officer of NovaBridge Biosciences. In this capacity, he is considered an officer of the company and is required to report his beneficial ownership of company securities on Form 3 when he becomes subject to Section 16 reporting.

Why is this NovaBridge Biosciences (NBP) Form 3 important for investors?

This Form 3 establishes the baseline ownership of the Chief Investment Officer at 874,000 Ordinary Shares (380,000 ADSs). Knowing insider holdings helps investors understand how much equity key executives have at stake when they begin reporting under insider ownership rules.